Nilotinib Drug Information
Nilotinib (Tasigna®) is a medication used to treat chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow. This medicine is approved for use in people age 18 and older. Nilotinib comes in the form of a capsule that is taken twice daily on an empty stomach. Possible side effects may include fatigue, nausea, and headaches.
To ensure your safety with nilotinib, make sure your healthcare provider has up-to-date information on any other drugs you are taking (including vitamins and supplements), as well as any allergies you may have (including to medications, foods, dyes, or preservatives). Also, let your healthcare provider know if you are pregnant or breastfeeding.
(To read the complete article on this drug, click Nilotinib. This Web page provides information on how this product works, what to expect, and important safety warnings to be aware of before beginning treatment.)